BUPA Finance PLC
29 September 2026
RNS
LEI Number: ZIMCVQHUFZ8GVHENP290
29 September 2026
Bupa Finance plc Announces Successful Issue of £300,000,000 6.875 per cent. Fixed Rate Subordinated Notes due 2038
Bupa Finance plc ("Bupa") today announces that on 29 September 2026 it successfully issued £300,000,000 6.875 per cent. Fixed Rate Subordinated Notes due 2038 (the "Notes"). The Notes are subject to the terms and conditions set out in the admission particulars dated 25 September 2026 relating to the Notes.
Application has been made to the London Stock Exchange plc for the Notes to be admitted to trading on the International Securities Market.
Bupa's Group Chief Financial Officer, James Lenton said:
"This new Tier 2 bond issue, in addition to the Tier 2 notes issued in November 2025, enable us to enhance Bupa's capital base and demonstrate the continued financial flexibility of the Group. We are very pleased with the demonstration of support from our fixed income investor base - and thank them for their ongoing support - as we continue to focus on delivering our 3x100 strategy and building towards our ambition of being the world's most customer-centric healthcare company."
Notes to editor
Enquiries
Investors
Mike Lunn (Group Treasury and Capital Management Director): ir@bupa.com
Media
External Relations: external.relations@bupa.com
About Bupa
Established in 1947, Bupa's purpose is helping people live longer, healthier, happier lives and making a better world. We are an international healthcare company serving 68 million customers worldwide. With no shareholders, we reinvest profits into providing more and better healthcare for the benefit of current and future customers. Bupa has businesses around the world, principally in Australia, the UK, Spain, Poland, Chile, Hong Kong SAR, India, Türkiye, Brazil, Mexico and New Zealand. We also have associate businesses in Saudi Arabia
For more information, visit www.bupa.com.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
ENDRNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.